Targeting CD84 and the CD304-Gal1 axis are other strategies used in myeloma mouse models to restore anti-myeloma T-cell responses by reducing MDSC accumulation and PD-L1 expression (45). The gene discussed is NRP1; the disease is plasma cell myeloma.